Modern Diagnostic & Research Centre Limited IPO: Modern Diagnostic & Research Centre Limited, a company providing diagnostic and healthcare testing services, is launching its IPO on December 31st.
Modern Diagnostic & Research Centre Limited IPO: Modern Diagnostic & Research Centre Limited, a major company in the healthcare and diagnostic sector, is launching its IPO. This will be the last IPO of the year. It is a book-built issue worth ₹36.89 crore.
This IPO is entirely a fresh issue. Modern Diagnostic is launching its IPO on December 31st, and investors can bid until January 2, 2026. Share allotment under the IPO is expected on January 5, 2026. The company's stock is likely to be listed on the BSE and NSE on January 7, 2026.
What is the Price Band?
The company has fixed the price band for the IPO at ₹85 to ₹90 per share. One lot will consist of 1600 shares. Retail investors will have to apply for a minimum of two lots, i.e., 3200 shares. Based on the upper price band, a minimum investment of ₹2.88 lakh will be required. A minimum of 3 lots are reserved for HNI investors in the Modern Diagnostic & Research Centre IPO.
What does the company do?
Modern Diagnostic & Research Centre, a diagnostic service provider, offers testing facilities in segments such as forensic pathology, anatomical pathology, and molecular pathology. The company also provides radiology services, including X-rays, ultrasounds, CT scans, MRIs, and mammography. It has 21 centers across 8 states in the country. Of these, 17 are laboratories and four are diagnostic centers. Launched in 1985, this diagnostic chain specializes in identifying diseases through medical testing facilities.
How will the funds be used?
The funds raised through the IPO will be used by the company to purchase medical equipment for its diagnostic centers and laboratories, meet working capital requirements, repay existing debt, and for general corporate purposes.
Disclaimer: (The information provided here is for informational purposes only. It is important to note that investments in the market are subject to market risks. Always consult an expert before investing. India Employment News does not advise anyone to invest money.)
-
‘Shame on BCCI’: Fans disappointed over no live coverage of Virat Kohli, Rohit Sharma matches in…

-
Divya Bharti’s last night explained: What happened before the fall that still haunts Bollywood after 32 years

-
Every word Enzo Maresca said on Chelsea injury boosts, Antoine Semenyo transfer, Aston Villa

-
TECH EXPLAINED: How Much Water is AI Consuming? A New Study Reveals Shocking Findings. Here's the Full Information

-
Enzo Maresca makes feelings crystal clear on Cole Palmer vs Morgan Rogers debate
